Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Benzamide, N-[4-methyl-3-[[4-(6-methyl-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]- | This product is a kinase inhibitor used in the treatment of certain types of cancer, including non-small cell lung cancer and pancreatic cancer. It works by inhibiting specific enzymes involved in cell growth and proliferation, ultimately leading to tumor regression. Group: Pharmaceutical. Alternative Names: N-[4-methyl-3-[[4-(6-methylpyridin-3-yl)pyrimidin-2-yl]amino]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide; CHEMBL1079113; 1032314-85-4; SCHEMBL11939618; BDBM50313640; ZINC49018631. CAS No. 1032314-85-4. Pack Sizes: 10 mg. Product ID: B2699-456548. Molecular formula: C30H33N7O. Mole weight: 507.63. Custom synthesis is available. Send your inquiries for more information. |  London |
| 2-{3-[5-(2-Hydroxypropan-2-yl)-1H-1,3-benzodiazol-1-yl]phenyl}benzamide | A GABAA receptor modulator that effects against anxiety. Group: Pharmaceutical. Alternative Names: 3'-(5-(2-Hydroxypropan-2-yl)-1H-benzo[d]imidazol-1-yl)-[1,1'-biphenyl]-2-carboxamide; GABAA Modulator I; SCHEMBL1761811; MFCD30186081; AKOS027439948; ZINC117027649. CAS No. 951654-29-8. Pack Sizes: 10 mg. Product ID: B0084-284807. Molecular formula: C23H21N3O2. Mole weight: 371.44. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-((3-Iodo-1H-indazol-6-yl)thio)-N-methylbenzamide | An impurity of Axitinib, a tyrosine kinase inhibitor used for the treatment of kidney cancer. Group: Pharmaceutical. Alternative Names: Benzamide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-methyl-. CAS No. 885126-34-1. Pack Sizes: 100 mg. Product ID: B2694-467100. Molecular formula: C15H12IN3OS. Mole weight: 409.25. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Chloro-N-((3-chloro-5-fluorophenyl)carbamothioyl)benzamide | 3-Chloro-N-((3-chloro-5-fluorophenyl)carbamothioyl)benzamide is a novel chemical entity that is widely employed in scientific investigations aimed at uncovering the therapeutic potential of diverse human diseases. Recent evidence suggests that this compound may offer a promising mode of action in the treatment of select cancer types. Although ongoing research continues to elucidate its safety and effectiveness, the preliminary findings hold considerable promise for this molecule as a potentially life-saving drug candidate. Group: Pharmaceutical. Alternative Names: 3-Chloro-N-[[(3-chloro-5-fluorophenyl)amino]thioxomethyl]benzamide; Benzamide, 3-chloro-N-[[(3-chloro-5-fluorophenyl)amino]thioxomethyl]-. CAS No. 1796641-12-7. Pack Sizes: 50 mg. Product ID: B0001-284777. Molecular formula: C14H9Cl2FN2OS. Mole weight: 343.2. Custom synthesis is available. Send your inquiries for more information. | London |
| 4-Chloro-N,N-diethylbenzamide | 4-Chloro-N,N-diethylbenzamide, a versatile chemical entity of interest to the biomedical community, is a potent insect repellent capable of the control of ticks and mosquitoes. In recent research, this agent has demonstrated promising results in the pharmacological realm as a treatment modality for the mitigation of neuropathic pain and certain oncological indications. Group: Pharmaceutical. Alternative Names: Benzamide, 4-chloro-N,N-diethyl-. CAS No. 7461-38-3. Pack Sizes: 500 mg. Product ID: B0001-284757. Molecular formula: C11H14ClNO. Mole weight: 211.689. Custom synthesis is available. Send your inquiries for more information. | London |
| N-[2-(diethylamino)ethyl]-2-iodobenzamide | N-[2-(diethylamino)ethyl]-2-iodobenzamide is used as a radiopharmaceutical for the scintigraphic detection of melanoma and metastases. Group: Pharmaceutical. Alternative Names: I-BZA2; 2-iodo-N-(2-diethylamino-ethyl)benzamide. CAS No. 170794-62-4. Pack Sizes: 1mg;1g;10g. Product ID: 170794-62-4. Molecular formula: C13H19IN2O. Mole weight: 346.21. Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide | (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide is an impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. Alternative Names: Alogliptin Impurity 14; Alogliptin Carbamoyl Impurity. CAS No. 1820685-30-0. Pack Sizes: 100 mg. Product ID: B1370-377540. Molecular formula: C18H23N5O3. Mole weight: 357.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfabenzamide-[d4] | Sulfabenzamide-[d4] is the labelled analogue of Sulfabenzamide, an antimicrobial agent. Group: Pharmaceutical. Alternative Names: Sulfabenzamide-d4; N-[(4-Aminophenyl)sulfonyl]-benzamide-d4; N-(Benzoyl)-4-aminobenzenesulfonamide-d4; N1-Benzoylsulfanilamide-d4. Pack Sizes: 5 mg. Product ID: BLP-014117. Molecular formula: C13H8D4N2O3S. Mole weight: 280.34. Custom synthesis is available. Send your inquiries for more information. | London |
| 1S,2S-DHAC-Phenyl Trost Ligand | 1S,2S-DHAC-Phenyl Trost Ligand is a reactive molecule that is used in synthesis of epoxides and jatrophane diterpenes. Group: Pharmaceutical. Alternative Names: (S,S)-DACH-phenyl Trost ligand; N,N'-((1S,2S)-cyclohexane-1,2-diyl)bis(2-(diphenylphosphino)benzamide); (S,S)-DACH-Ph. CAS No. 169689-05-8. Pack Sizes: 10 g. Product ID: B1370-224168. Molecular formula: C44H40N2O2P2. Mole weight: 690.75. Custom synthesis is available. Send your inquiries for more information. | London |
| 5'-O-DMT-2'-O-TBDMS-N6-Benzoyl-L-Adenosine 3'-CE phosphoramidite | 5'-O-DMT-2'-O-TBDMS-N6-Benzoyl-L-Adenosine 3'-CE phosphoramidite is a crucial reagent used in the synthesis of oligonucleotides for biomedical research. It enables the efficient introduction of N6-benzoyl-L-Adenosine residues into the oligonucleotide chain, thus allowing the study of adenosine-modified nucleic acids. This product finds applications in drug discovery, gene therapy, and understanding diseases related to adenosine signaling pathways. Group: Pharmaceutical. Alternative Names: Benzamide, N-[9-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-β-L-ribofuranosyl]-9H-purin-6-yl]-; N-Benzoyl-9-{5-O-[bis(4-methoxyphenyl)(phenyl)methyl]-3-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2-O-[dimethyl(2-methyl-2-propanyl)silyl]-β-L-ribofuranosyl}-9H-purin-6-amine; DMT-2'-O-TBDMS-L-rA(Bz) Phosphoramidite; 5'-O-DMTr-2'-O-TBDMS-L-A(Bz)-3'-CE-Phosphoramidite; N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-(t-butyl-dimethylsilyl)-L-adenosine-3'-cyanoethyl Phosphoramidite. CAS No. 1803193-36-3. Pack Sizes: 1 g. Product ID: B1370-291981. Molecular formula: C53H66N7O8PSi. Mole weight: 988.21. Custom synthesis is available. Send your inquiries for more information. | London |
| 5'-O-DMT-N4-benzoyl-2'-fluoro-2'-deoxycytidine | 5'-O-DMT-N4-benzoyl-2'-fluoro-2'-deoxycytidine boasts a promising pharmacological arsenal to combat a range of viral infections. With virucidal efficacy that targets the DNA replication machinery of several virus strains, the drug holds considerable therapeutic potential for cases of hepatitis B and C, as well as herpes and shingles. Furthermore, its anti-neoplastic properties make it a noteworthy exploratory tool for certain types of cancer treatment. Group: Pharmaceutical. Alternative Names: 5'-O-(4,4'-dimethoxytrityl)-N4-benzoyl-2'-fluoro-2'-deoxycytidine; N4-Bz-DMT-2'-F-dC; N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-D-cytidine; N4-Benzoyl-5'-O-DMT-2'-fluoro-2'-deoxycytidine; N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluorocytidine; 5'-O-DMTr-2'-F-dC(Bz); 5'-DMT-2'-F-Bz-dC; 5'-O-(4,4'-dimethoxytrityl)-N6-Benzoyl-2'-fluoro-2'-deoxyadenosine; N-{1-{5-O-[bis-(4-methoxyphenyl)phenylmethyl]-2-deoxy-2-fluoro-D-arabinofuranosyl}-1,2-dihydro-2-oxo-4-pyrimidinyl}-benzamide; N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluoro-Cytidine; 5'-O-DMT-N4-Bz-2'-F-dC. CAS No. 146954-77-0. Pack Sizes: 5 g. Product ID: B1370-376765. Molecular formula: C37H34FN3O7. Mole weight: 651.68. Custom synthesis is available. Send your inquiries for more information. | London |
| AAL-993 | AAL-993 is a VEGFR tyrosine kinase inhibitor that possesses dual inhibition of VEGFR signaling and HIF-1α expression through ERK inhibition without affecting Akt phosphorylation. Group: Pharmaceutical. Alternative Names: AAL 993; AAL993; 2-((4-pyridyl)methyl)amino-N-(3-(trifluoromethyl)phenyl)benzamide. CAS No. 269390-77-4. Pack Sizes: 1mg;1g;10g. Product ID: 269390-77-4. Molecular formula: C20H16F3N3O. Mole weight: 371.36. Custom synthesis is available. Send your inquiries for more information. | London |
| ABBV-167 | ABBV-167 is a phosphate prodrug of venetoclax, a Bcl-2 inhibitor. Group: Pharmaceutical. Alternative Names: Benzamide, 4-(4-((2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl)methyl)-1-piperazinyl)-N-((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)sulfonyl)-2-((7-((phosphonooxy)methyl)-7H-pyrrolo(2,3-b)pyridin-5-yl)oxy)-; (5-{5-(4-{[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl}-1-piperazinyl)-2-[({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)carbamoyl]phenoxy}-7H-pyrrolo[2,3-b]pyridin-7-yl)methyl dihydrogen phosphate. CAS No. 1351456-78-4. Pack Sizes: 1mg;1g;10g. Product ID: 1351456-78-4. Molecular formula: C46H53ClN7O11PS. Mole weight: 978.45. Custom synthesis is available. Send your inquiries for more information. | London |
| ABT670 | ABT670 is a drug which acts as a potent, superior orally bioavailable dopamine agonist selective for the D4 subtype. It was used as a possible treatment for erectile dysfunction. Uses: Abt670 was used as a possible treatment for erectile dysfunction. Group: Pharmaceutical. Alternative Names: ABT-670; ABT 670; Benzamide, 3-methyl-N-[[4-(1-oxido-2-pyridinyl)-1-piperidinyl]methyl]-;3-Methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-(2,4'-bipyridine)-1'-ylmethyl)benzamide. CAS No. 630119-43-6. Pack Sizes: 1mg;1g;10g. Product ID: 630119-43-6. Molecular formula: C19H23N3O2. Mole weight: 325.41. Custom synthesis is available. Send your inquiries for more information. | London |
| ABT-737 | ABT-737 is a potent, cell-permeable mimetic of BH3 domains that avidly binds Bcl-2, Bcl-xL, and Bcl-W (Ki < 1 nM for all three proteins). It blocks the interaction of these proteins with pro-death proteins, leading to apoptosis. Group: Pharmaceutical. Alternative Names: ABT 737; ABT737; (R)-4-(4-((4'-chloro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-(dimethylamino)-1-(phenylthio)butan-2-yl)amino)-3-nitrophenyl)sulfonyl)benzamide. CAS No. 852808-04-9. Pack Sizes: 100 mg. Product ID: B1370-139061. Molecular formula: C42H45ClN6O5S2. Mole weight: 813.43. Custom synthesis is available. Send your inquiries for more information. | London |
| AC-55541 | AC-55541 is a novel small-molecule protease-activated receptor 2(PAR2) agonist which displays no activity at other PAR subtypes or at over 30 other receptors involved in nociception and inflammation. It activated PAR2 signaling in cellular proliferation assays, phosphatidylinositol hydrolysis assays, and Ca(2+) mobilization assays, with potencies ranging from 200 to 1000 nM. It was well absorbed when administered intraperitoneally to rats, reaching micromolar peak plasma concentrations. It was stable to metabolism by liver microsomes and maintained sustained exposure in rats. Uses: Ac-55541 stimulates cell proliferation, phosphatidylinositol hydrolysis, and calcium mobilization. Group: Pharmaceutical. Alternative Names: AC-55541; AC 55541; AC55541. (2E)-2-[1-(3-Bromophenyl)ethylidene]α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineaceticacidhydrazide;AC 55541;alpha-(Benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineacetic acid (2E)-2-[1-(3-bromophenyl)ethylidene]hydrazide;N-[2-[(2E)-2-[1-(3-bromophenyl)ethylidene]hydrazinyl]-2-oxo-1-(4-oxo-3H-phthalazin-1-yl)ethyl]benzamide. CAS No. 916170-19-9. Pack Sizes: 300 mg. Product ID: B0084-271988. Molecular formula: C25H20BrN5O3. Mole weight: 518.36. Custom synthesis is available. Send your inquiries for more information. | London |
| Acalabrutinib-[d4] | Acalabrutinib-[d4] is a labelled version of Acalabrutinib. Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. It inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. Group: Pharmaceutical. Alternative Names: (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl-d4)benzamide; Acalabrutinib D4; Acalabrutinib-d4; 4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide-d4; ACP 196-d4; Calquence-d4. CAS No. 2699608-18-7. Pack Sizes: 5 mg. Product ID: BLP-003188. Molecular formula: C26H19D4N7O2. Mole weight: 469.53. Custom synthesis is available. Send your inquiries for more information. | London |
| ARD-2128 | ARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor degrader. It effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. Group: Pharmaceutical. Alternative Names: ARD2128; ARD 2128; N-[(1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl]-4-[4-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]piperazin-1-yl]benzamide. CAS No. 2222111-87-5. Pack Sizes: 25 mg. Product ID: B1370-380960. Molecular formula: C45H50ClN7O6. Mole weight: 820.37. Custom synthesis is available. Send your inquiries for more information. | London |
| AU-224 | AU-224, a benzamide derivative, exhibited potent gastro- and colon-prokinetic activities by oral administration without significant side effects. Group: Pharmaceutical. Alternative Names: 1-Piperidineacetic acid, 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-, butyl ester; butyl 2-[4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]piperidin-1-yl]acetate; AU-224; butyl 4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-1-piperidineacetate; AU 224;AU224. CAS No. 287399-47-7. Pack Sizes: 1mg;1g;10g. Product ID: 287399-47-7. Molecular formula: C19H28ClN3O4. Mole weight: 397.9. Custom synthesis is available. Send your inquiries for more information. | London |
| Axitinib | Axitinib (AG013736) is a tyrosine kinase inhibitor developed by Pfizer. Axitinib is a tyrosine kinase inhibitor that blocks the activation of VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFRβ (IC50 = 1.2, 0.25, 0.29, 1.7, and 1.6 nM, respectively). It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models. Uses: Protein kinase inhibitors. Group: Pharmaceutical. Alternative Names: AG 013736; N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-benzamide; Inlyta. CAS No. 319460-85-0. Pack Sizes: 5 g. Product ID: NP3631. Molecular formula: C22H18N4OS. Mole weight: 386.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Axitinib sulfoxide | A major metabolite of Axitinib, a tyrosine kinase inhibitor used for the treatment of kidney cancer. Group: Pharmaceutical. Alternative Names: N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfinyl]-benzamide; Axitinib Impurity A. CAS No. 1347304-18-0. Pack Sizes: 10 mg. Product ID: B2694-467095. Molecular formula: C22H18N4O2S. Mole weight: 402.48. Custom synthesis is available. Send your inquiries for more information. | London |
| AZD-4547 | AZD4547 is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. AZD4547 binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways, and, so, the inhibition of tumor cell proliferation and tumor cell death. Group: Pharmaceutical. Alternative Names: AZD-4547; AZD 4547; AZD4547; N-{3-[2-(3,5-Dimethoxyphenyl)ethyl]-1h-Pyrazol-5-Yl}-4-[(3r,5s)-3,5-Dimethylpiperazin-1-Yl]benzamide. CAS No. 1035270-39-3. Pack Sizes: 100 mg. Product ID: B0084-456576. Molecular formula: C26H33N5O3. Mole weight: 463.582. Custom synthesis is available. Send your inquiries for more information. | London |
| AZD-7594 | AZD-7594 is an inhaled selective glucocorticoid receptor (GCCR) modulator. Group: Pharmaceutical. Alternative Names: AZD-7594; AZD 7594; AZD7594; AZ13189620; AZ-13189620; AZ 13189620; 3-[5-[(1R,2S)-2-(2,2-difluoropropanoylamino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy]indazol-1-yl]-N-[(3R)-oxolan-3-yl]benzamide. CAS No. 1196509-60-0. Pack Sizes: 10 mg. Product ID: B0084-260278. Molecular formula: C32H32F2N4O6. Mole weight: 606.627. Custom synthesis is available. Send your inquiries for more information. | London |
| Benodanil | Benodanil is an internal fungicide that can control rust in cereals, coffee, tobacco, vegetables, and ornamental plants. Group: Pharmaceutical. Alternative Names: Benzamide, 2-iodo-N-phenyl-; Benzanilide, 2-iodo-; 2-Iodobenzanilide; 2-Iodobenzoic acid anilide; BAS 3170; BAS 31700F; BAS 31702F; BAS 31708F; BAS 31709; BAS 3170F; BAS 3172F; BASF 31709F; Benefit; Benodanyl; Calirus; NSC 100499; o-Iodobenzanilide. CAS No. 15310-01-7. Pack Sizes: 1mg;1g;10g. Product ID: 15310-01-7. Molecular formula: C13H10INO. Mole weight: 323.13. Custom synthesis is available. Send your inquiries for more information. | London |
| BI-2536 | BI-2563 is a small molecule compound with potential antineoplastic activities. BI 2536 binds to and inhibits Polo-like kinase 1 (Plk1), resulting in mitotic arrest, disruption of cytokinesis, and apoptosis in susceptible tumor cell populations. Plk1, a serine/threonine-protein kinase, is a key regulator of multiple processes fundamental to mitosis and cell division. Group: Pharmaceutical. Alternative Names: BI2536; BI 2536; (R)-4-((8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide. CAS No. 755038-02-9. Pack Sizes: 50 mg. Product ID: B1370-076522. Molecular formula: C28H39N7O3. Mole weight: 521.65. Custom synthesis is available. Send your inquiries for more information. | London |
| Broflanilide | Broflanilide, a GABA antagonist, is an insecticide that has high larvicidal activity against Spodoptera litura and is effective against pests with resistance to cyclodienes and fipronil. Group: Pharmaceutical. Alternative Names: N-[2-Bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)phenyl]-2-fluoro-3-(N-methylbenzamido)benzamide; 3-(Benzoylmethylamino)-N-[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-2-fluorobenzamide; 2-Fluoro-3-(N-methylbenzamido)-N-[2-bromo-4-(heptafluoroisopropyl)-6-(trifluoromethyl)phenyl]benzamide; 6'-Bromo-α,α,α,2-tetrafluoro-3-(N-methylbenzamido)-4'-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]benz-o-toluidide. CAS No. 1207727-04-5. Pack Sizes: 50 mg. Product ID: B1370-071090. Molecular formula: C25H14BrF11N2O2. Mole weight: 663.28. Custom synthesis is available. Send your inquiries for more information. | London |
| Bryonamide A | Bryonamide A is an alkaloid isolated from Bryonia aspera. Group: Pharmaceutical. Alternative Names: 4-Hydroxy-N-(2-hydroxyethyl)benzamide; N-(2-Hydroxyethyl)-4-hydroxybenzamide; Benzamide, 4-hydroxy-N-(2-hydroxyethyl)-. CAS No. 75268-14-3. Pack Sizes: 1 mg. Product ID: NP0825. Molecular formula: C9H11NO3. Mole weight: 181.191. Custom synthesis is available. Send your inquiries for more information. | London |
| CGI1746 | CGI1746 is a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation. CGI1746 has exquisite selectivity for Btk and inhibits both auto- and transphosphorylation steps necessary for enzyme activation. Group: Pharmaceutical. Alternative Names: CGI1746; CGI-1746; CGI 1746. 4-(tert-Butyl)-N-(2-methyl-3-(4-methyl-6-((4-(morpholine-4-carbonyl)phenyl)amino)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)benzamide. CAS No. 910232-84-7. Pack Sizes: 100 mg. Product ID: B0084-430556. Molecular formula: C34H37N5O4. Mole weight: 579.69. Custom synthesis is available. Send your inquiries for more information. | London |
| CHIR-090 | CHIR-090 is a very potent and tight-binding inhibitor of LpxC, which is a zinc-dependent amidase and present in almost all Gram-negative bacteria, and is a promising target for the development of novel antibiotic substances against multigrug-resistant Gram-negative bacteria. Its Ki value is 4.0 nM. It displays two-step time-dependent inhibition and kills a wide range of Gram-negative pathogens as effectively as ciprofloxacin or tobramycin. It has a different selectivity with the reported LpxC inhibitor L-161. It has excellent antibiotic activity against Pseudomonas aeruginosa and Escherichia coli by inhibiting LpxC orthologs at low nM concentrations. It is an excellent lead for the further development of new antibiotics targeting the lipid A pathway. Uses: Chir-090 displays two-step time-dependent inhibition and kills a wide range of gram-negative pathogens as effectively as ciprofloxacin or tobramycin. it has excellent antibiotic activity against pseudomonas aeruginosa and escherichia coli by inhibiting lpxc orthologs at low nm concentrations. Group: Pharmaceutical. Alternative Names: CHIR-090; CHIR 090; CHIR090. N-[(1S,2R)-2-Hydroxy-1-[(hydroxyamino)carbonyl]propyl]-4-[[4-(4-morpholinylmethyl)phenyl]ethynyl]benzamide. CAS No. 728865-23-4. Pack Sizes: 300 mg. Product ID: B0084-474822. Molecular formula: C24H27N3O5. Mole weight: 437.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Cinitapride | Cinitapride is a gastroprokinetic agent and antiemetic agent of the benzamide class. It acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors. Group: Pharmaceutical. Alternative Names: Benzamide, 4-amino-N-[1-(3-cyclohexen-1-ylmethyl)-4-piperidinyl]-2-ethoxy-5-nitro-; 4-Amino-N-[1-(3-cyclohexen-1-ylmethyl)-4-piperidinyl]-2-ethoxy-5-nitrobenzamide. CAS No. 66564-14-5. Pack Sizes: 100 mg. Product ID: B2692-468999. Molecular formula: C21H30N4O4. Mole weight: 402.49. Custom synthesis is available. Send your inquiries for more information. | London |
| CXD101 | CXD101 is a selective histone deacetylase (HDAC) inhibitor with IC50 of 63 nM, 570 nM and 550 nM for HDAC1, HDAC2 and HDAC3, respectively. It exhibits antineoplastic activity. Group: Pharmaceutical. Alternative Names: HDAC-IN-4; CXD-101; CXD 101; N-(2-Aminophenyl)-4-(1-((1,3-dimethyl-1H-pyrazol-4-yl)methyl)piperidin-4-yl)benzamide. CAS No. 934828-12-3. Pack Sizes: 10 mg. Product ID: B1370-379907. Molecular formula: C24H29N5O. Mole weight: 403.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Cyt387 | Cyt387 is an ATP-competitive inhibitor of JAK1 and JAK2 (IC50 = 11 nM and 18 nM respectively). It has been shown to decrease cancer stem cell associated tumor burden in a mouse model of human ovarian cancer. It is commonly used as a therapy for myelofibrosis. Uses: An orally bioavailable small-molecule inhibitor of janus kinases 1 and 2 (jak1/2) with potential antineoplastic activity (ic50s = 11 and 18 nm, respectively). Group: Pharmaceutical. Alternative Names: Momelotinib; N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide; CYT 11387; CYT 387; CYT-387; CYT387; CYT-0387; GS 0387. CAS No. 1056634-68-4. Pack Sizes: 50 mg. Product ID: B0084-307720. Molecular formula: C23H22N6O2. Mole weight: 414.46. Custom synthesis is available. Send your inquiries for more information. | London |
| Defactinib | Defactinib, also known as VS-6063 and PF-04554878, is an orally bioavailable, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. FAK inhibitor PF-04554878 inhibits FAK, which may prevent the integrin-mediated activation of several downstream signal transduction pathways, including ERK, JNK/MAPK and PI3K/Akt, thus inhibiting tumor cell migration, proliferation and survival. The tyrosine kinase FAK is , a signal transducer for integrins that is upregulated in many tumor cell types and is involved in tumor cell invasion, migration and proliferation. Group: Pharmaceutical. Alternative Names: N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide; VS6063; VS 6063; VS-6063; PF04554878; PF-04554878; PF 04554878; PF4554878; PF-4554878. CAS No. 1073154-85-4. Pack Sizes: 200 mg. Product ID: B0084-462762. Molecular formula: C20H21F3N8O3S. Mole weight: 510.496. Custom synthesis is available. Send your inquiries for more information. | London |
| Des-4-fluorobenzyl Mosapride | Des-4-fluorobenzyl Mosapride is an impurity of Mosapride. Mosapride is a 5-HT4 receptor agonist and 5-HT3 receptor antagonist. It is used as a gastroprokinetic agent. Group: Pharmaceutical. Alternative Names: Des-p-fluorobenzyl mosapride; Mosapride Impurity 5; 4-amino-5-chloro-2-ethoxy-N-((2-morpholinyl)methyl)benzamide. CAS No. 152013-26-8. Pack Sizes: 50 mg. Product ID: B1370-260359. Molecular formula: C14H20ClN3O3. Mole weight: 313.79. Custom synthesis is available. Send your inquiries for more information. | London |
| Diflubenzuron | Diflubenzuron is a benzoylurea-type insecticide of the benzamide class. The mechanism of action of diflubenzuron involves inhibiting the production of chitin which is used by an insect to build its exoskeleton. Group: Pharmaceutical. Alternative Names: Difluron; Dimilin; Larvakil; N-[(4-chlorophenyl)carbamoyl]-2,6-difluorobenzamide. CAS No. 35367-38-5. Pack Sizes: 1mg;1g;10g. Product ID: 35367-38-5. Molecular formula: C14H9ClF2N2O2. Mole weight: 310.685. Custom synthesis is available. Send your inquiries for more information. | London |
| Entrectinib | Entrectinib (RXDX-101) is an orally bioavailable pan-TrkA/B/C, ROS1 and ALK inhibitor with IC50 ranging between 0.1 and 1.7 nM. Phase 2. Uses: Protein kinase inhibitors. Group: Pharmaceutical. Alternative Names: RXDX101; RXDX 101; RXDX-101; NMS E628; NMS-E628; Entrectinib; N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide. CAS No. 1108743-60-7. Pack Sizes: 250 mg. Product ID: B0084-470812. Molecular formula: C31H34F2N6O2. Mole weight: 560.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Enzalutamide | Enzalutamide is an androgen-receptor (AR) antagonist with IC50 of 36 nM. It inhibits the activity of prostate cancer cell Ars, which over expressed in prostate cancer. Uses: Potential antineoplastic agent. Group: Pharmaceutical. Alternative Names: MDV3100; MDV 3100; MDV-3100; 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide; Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-; 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; S-Enzalutamide; Xtandi. CAS No. 915087-33-1. Pack Sizes: 500 mg. Product ID: B0084-155497. Molecular formula: C21H16F4N4O2S. Mole weight: 464.44. Custom synthesis is available. Send your inquiries for more information. | London |
| Etosalamide | Etosalamide is an anti-inflammatory agent with antipyretic and analgesics properties. Group: Pharmaceutical. Alternative Names: 2-(2-ethoxyethoxy)benzamideEtosalamide; ethosalamide; UNII-1PU994YJUH; Etosalamide [INN]; AC1L4LNV; AC1Q5FQ9; 1PU994YJUH; 2-(2-ethoxyethoxy)benzamide; SCHEMBL2109187; SCHEMBL-2109187; SCHEMBL 2109187; CHEMBL2104260; CHEMBL 2104260; CHEMBL-2104260; HY-B1015; ZINC3623372; ZINC 3623372; ZINC-3623372; AR-1I7815; CCG-213900; CCG213900; CCG 213900; CS-4528; CS4528; CS 4528O; R224796; R-224796; R 224796; AB01563362_01. CAS No. 15302-15-5. Pack Sizes: 1mg;1g;10g. Product ID: 15302-15-5. Molecular formula: C11H15NO3. Mole weight: 209.24. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluralaner | Fluralaner is a systemic insecticide and acaricide. It can be used for flea treatment in dogs. Uses: Flea treatment in dogs. Group: Pharmaceutical. Alternative Names: AH252723; AH-252723; AH 252723; A-1443; A1443; A 1443; Fluralaner, trade name: Bravecto. 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide. CAS No. 864731-61-3. Pack Sizes: 100 mg. Product ID: B0084-476691. Molecular formula: C22H17Cl2F6N3O3. Mole weight: 556.29. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluxametamide | Fluxametamide, a broad-spectrum insecticide, is an antagonist of GABA- and glutamate-gated chloride channels, with IC50s of 1.95 and 225 nM for M. domestica GABACls and GluCls. Group: Pharmaceutical. Alternative Names: 4-(5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl)-N-((methoxyimino)methyl)-2-methylbenzamide; Benzamide, 4-(5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl)-N-((methoxyamino)methylene)-2-methyl-; 4-[5-(3,5-Dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-1,2-oxazol-3-yl]-N-[(methoxyimino)methyl]-o-toluamide. CAS No. 928783-29-3. Pack Sizes: 500 mg. Product ID: B1370-381842. Molecular formula: C20H16Cl2F3N3O3. Mole weight: 474.26. Custom synthesis is available. Send your inquiries for more information. | London |
| GP2-114 | GP2-114, a long-acting, highly potent catecholamine, produces current-dependent cardiovascular action when administered by transdermal iontophoresis. Group: Pharmaceutical. Alternative Names: 4-[3-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]butyl]benzamide; 1-(3,4-dihydroxyphenyl)-2-(3-(4-carbamylphenyl)-1-methylpropylamino)ethanol; GP 114; GP 2-114; GP 2-128; GP 2-128 (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1); GP 2-128 monoacetate; GP-114; GP-2-114; GP-2-128. CAS No. 130783-39-0. Pack Sizes: 1mg;1g;10g. Product ID: 130783-39-0. Molecular formula: C19H24N2O4. Mole weight: 344.4. Custom synthesis is available. Send your inquiries for more information. | London |
| GSK-7975A | This active molecular is a calcium release-activated calcium modulator (ORAI1) inhibitor. GSK-7975A inhibited toxin-induced activation of ORAI1 and/or activation of Ca(2+) currents after Ca(2+) release in mouse and human pancreatic acinar cells. GSK-7975A may be used for the treatment of pancreatitis in the future. Uses: Pancreatitis. Group: Pharmaceutical. Alternative Names: GSK-7975A; GSK 7975A; GSK7975A; GSK-7975; GSK 7975; GSK7975. SCHEMBL705705; AOB4124; CPYTVBALBFSXSH-UHFFFAOYSA-N;2,6-difluoro-N-[1-[[4-hydroxy-2-(trifluoromethyl)phenyl]methyl]pyrazol-3-yl]benzamide. CAS No. 1253186-56-9. Pack Sizes: 50 mg. Product ID: B0084-475226. Molecular formula: C18H12F5N3O2. Mole weight: 397.31. Custom synthesis is available. Send your inquiries for more information. | London |
| HY-17542 | HY-17542 is a potent inhibitor of papain-like protease (PLpro) with IC50 of 2.6 μM. Group: Pharmaceutical. Alternative Names: PLpro inhibitor 6; (R)-5-acetamido-2-methyl-N-(1-(naphthalen-1-yl)ethyl)benzamide; HY 17542; HY17542. CAS No. 1093070-14-4. Pack Sizes: 100 mg. Product ID: B1370-450321. Molecular formula: C22H22N2O2. Mole weight: 346.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Imatinib | Imatinib inhibits the SLF-dependent activation of wild-type c-kit kinase activity with an IC50 for these effects of approximately 0.1 μM, which is similar to the concentration required for inhibition of PDGFR. Imatinib is an oral chemotherapy agent used to treat cancers. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis, and myelodysplastic syndrome. Group: Pharmaceutical. Alternative Names: CGP057148B; STI571; Gleevec; Glivec; N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; 4-[(4-Methyl-1-piperazinyl)methyl]-N-(4-methyl-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}phenyl)benzamide. CAS No. 152459-95-5. Pack Sizes: 10 g. Product ID: BBF-05855. Molecular formula: C29H31N7O. Mole weight: 493.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Imatinib-[d4] | Imatinib-[d4] is an isotopically labelled analogue of Imatinib. Imatinib is an inhibitor of multiple tyrosine kinases. It is a COVID-19-related research product. Group: Pharmaceutical. Alternative Names: N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide-2,3,5,6-d4; Imatinib D4. CAS No. 1134803-16-9. Pack Sizes: 5 mg. Product ID: BLP-005865. Molecular formula: C29H27D4N7O. Mole weight: 497.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Imatinib EP Impurity J | An impurity of Imatinib, a tyrosine kinase receptor inhibitor used for cancer therapy. Group: Pharmaceutical. Alternative Names: Imatinib (Piperidine)-N-oxide; 4-[(4-Methyl-4-oxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide; CGP 71422; CGP71422; CGP-71422. CAS No. 571186-91-9. Pack Sizes: 10 mg. Product ID: B2694-473158. Molecular formula: C29H31N7O2. Mole weight: 509.62. Custom synthesis is available. Send your inquiries for more information. | London |
| Imatinib Guanidine Impurity | An impurity of Imatinib, a tyrosine kinase receptor inhibitor used for cancer therapy. Group: Pharmaceutical. Alternative Names: N-(3-Guanidino-4-methylphenyl)-4-(methylpiperazine-1-yl-methyl)benzamide; N-[3-[(Aminoiminomethyl)amino]-4-methylphenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide; N-[2-Methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]benzoyl]amino]phenyl]guanidine. CAS No. 581076-65-5. Pack Sizes: 100 mg. Product ID: B2694-257315. Molecular formula: C21H28N6O. Mole weight: 380.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Imatinib Impurity C | an impurity of Imatinib (Gleevec). Group: Pharmaceutical. Alternative Names: Imatinib (Piperidine)-1-oxide; 4-[(4-Methyl-1-oxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide. CAS No. 938082-57-6. Pack Sizes: 10 mg. Product ID: B2694-473162. Molecular formula: C29H31N7O2. Mole weight: 509.62. Custom synthesis is available. Send your inquiries for more information. | London |
| Imatinib Impurity E | an impurity of Imatinib (Gleevec). Group: Pharmaceutical. Alternative Names: Des(methylpiperazinyl-N-methyl) Imatinib Dimer Impurity; 4,4'-(piperazine-1,4-diylbis(methylene))bis(N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide). CAS No. 1365802-18-1. Pack Sizes: 10 mg. Product ID: B2694-473163. Molecular formula: C52H48N12O2. Mole weight: 873.04. Custom synthesis is available. Send your inquiries for more information. | London |
| Imatinib Related Substance B | An impurity of Imatinib, a tyrosine kinase receptor inhibitor used for cancer therapy. Group: Pharmaceutical. Alternative Names: Imatinib (Piperidine)-N,N-dioxide; 4-[(4-Methyl-1,4-dioxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide. CAS No. 571186-93-1. Pack Sizes: 5 mg. Product ID: B2694-473161. Molecular formula: C29H31N7O3. Mole weight: 525.62. Custom synthesis is available. Send your inquiries for more information. | London |
| INCB3344 | INCB3344 is a potent CCR2 antagonist with IC50 of 5.1 nM and 9.5 nM for hCCR2 and mCCR2, respectively. Group: Pharmaceutical. Alternative Names: INCB3344; INCB 3344; INCB-3344; N-(2-(((3S,4S)-1-(4-(Benzo[d][1,3]dioxol-5-yl)-4-hydroxycyclohexyl)-4-ethoxypyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide. CAS No. 1262238-11-8. Pack Sizes: 10 mg. Product ID: B0084-457803. Molecular formula: C29H34F3N3O6. Mole weight: 577.59. Custom synthesis is available. Send your inquiries for more information. | London |
| IRAK-1-4 Inhibitor I | IRAK-1-4 Inhibitor I is a novel benzimidazole that is a potent inhibitor of interleukin-1 receptor-associated kinases 1-4 (IRAK 1-4). Group: Pharmaceutical. Alternative Names: Benzamide, N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitro-. CAS No. 509093-47-4. Pack Sizes: 25 mg. Product ID: B2693-302024. Molecular formula: C20H21N5O4. Mole weight: 395.41. Custom synthesis is available. Send your inquiries for more information. | London |
| JK-P3 | JK-P3 is a VEGFR2 inhibitor with IC50 values of 7.8 μM. JK-P3 inhibits FGFR 1/3 kinase activity in vitro, but exhibits no effect on FGFR signaling in cell-based assays. It suppresses wound healing and tube formation in HUVEC without effecting endothelial cell proliferation. Group: Pharmaceutical. Alternative Names: 3,4-dimethoxy-N-(5-phenyl-1H-pyrazol-3-yl)benzamide. CAS No. 942655-44-9. Pack Sizes: 25 mg. Product ID: B0084-284855. Molecular formula: C18H17N3O3. Mole weight: 323.352. Custom synthesis is available. Send your inquiries for more information. | London |
| Lisaftoclax | Lisaftoclax is a dual Bcl-2 and Bcl-xl inhibitor with antineoplastic activity. Group: Pharmaceutical. Alternative Names: Bcl-2/Bcl-xl inhibitor 1; APG-2575; (S)-N-((4-(((1,4-dioxan-2-yl)methyl)amino)-3-nitrophenyl)sulfonyl)-2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl)methyl)piperazin-1-yl)benzamide. CAS No. 2180923-05-9. Pack Sizes: 5 mg. Product ID: B1370-373008. Molecular formula: C45H48ClN7O8S. Mole weight: 882.42. Custom synthesis is available. Send your inquiries for more information. | London |
| LY-2456302 | LY-2456302, also called as CERC-501, is a potent, highly selective and centrally-penetrant kappa opioid receptor antagonist (Ki = 0.807 nM) with favorable pharmacokinetic and pharmacodynamic properties to evaluate the role of KOR in preclinical models of alcoholism. Group: Pharmaceutical. Alternative Names: 4-[4-[[(2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl]methyl]phenoxy]-3-fluorobenzamide; 3-fluoro4-(4-((2-(3,5-dimethylphenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide; LY2456302; CERC-501; LY 2456302; CERC 501; LY-2456302; CERC501. CAS No. 1174130-61-0. Pack Sizes: 100 mg. Product ID: B2693-007347. Molecular formula: C26H27FN2O2. Mole weight: 418.5. Custom synthesis is available. Send your inquiries for more information. | London |
| MDK74978 | MDK74978 is a multi-kinase inhibitor. Group: Pharmaceutical. Alternative Names: N-(2-Hydroxyethyl)-4-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide; MDK74978; MDK-74978; MDK 74978. Multi-kinase inhibitor I. CAS No. 778274-97-8. Pack Sizes: 25 mg. Product ID: B0084-284808. Molecular formula: C20H17F3N4O3. Mole weight: 418.376. Custom synthesis is available. Send your inquiries for more information. | London |
| Moclobemide | Moclobemide is a reversible monoamine oxidase A (MAO-A) inhibitor, displaying antidepressive activity. Group: Pharmaceutical. Alternative Names: Ro11-1163; Ro 11-1163; Ro111163; Ro-111163; Ro 111163; Moclobemide; brand name: Amira; Aurorix; Clobemix; Depnil; Manerix; 4-chloro-N-(2-morpholin-4-ylethyl)benzamide. CAS No. 71320-77-9. Pack Sizes: 100 mg. Product ID: B0084-075760. Molecular formula: C13H17ClN2O2. Mole weight: 268.74. Custom synthesis is available. Send your inquiries for more information. | London |
| Monepantel | Monepantel, also known as AAD 1566, is a new anthelmintic agent used in the treatment of parasitic nematodes via stun or kill without damaging the host entity. Group: Pharmaceutical. Alternative Names: AAD1566; AAD 1566; N-(2-Cyano-1-((2S)-5-cyano-2-(trifluoromethyl)phenoxy)propan-2-yl)-4-(trifluoromethylsulfanyl)benzamide. CAS No. 887148-69-8. Pack Sizes: 1 g. Product ID: B1370-101979. Molecular formula: C20H13F6N3O2S. Mole weight: 473.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Mono-methyl terephthalate | Mono-methyl terephthalate is used in the synthesis of Hepatits C antiviral activity. Also used in the design and preparation of benzamide derivatives as BRAFV600E inhibitors, which if mutated, can influence malignancies and melanomas. Uses: Mono-methyl terephthalate is used in the synthesis of hepatits c antiviral activity. also used in the design and preparation of benzamide derivatives as brafv600e inhibitors, which if mutated, can influence malignancies and melanomas. Group: Pharmaceutical. Alternative Names: MMT; 1,4-Benzenedicarboxylic Acid Monomethyl Ester; Terephthalic Acid Monomethyl Ester; 4-(Carbomethoxy)benzoic Acid; 4-(Methoxycarbonyl)benzoic Acid; 4-[(Methyloxy)carbonyl]benzoic Acid; Hydrogen Methyl Terephthalate; Methyl 4-Carboxybenzoate; Methyl Hydrogen Terephthalate; Methyl p-Carboxybenzoate; Methyl p-Phthalate; Monomethyl terephthalate; NSC 210838; p-(Methoxycarbonyl)benzoic Acid; p-Carbomethoxybenzoic Acid. CAS No. 1679-64-7. Pack Sizes: 1mg;1g;10g. Product ID: BAT-006428. Molecular formula: C9H8O4. Mole weight: 180.16. Custom synthesis is available. Send your inquiries for more information. | London |
| Mosapride Citrate Dihydrate | Mosapride Citrate Dihydrate is a citrate hydrate form of Mosapride, which is a 5-HT4 receptor agonist and 5-HT3 receptor antagonist. It is used as a gastroprokinetic agent. Group: Pharmaceutical. Alternative Names: Mosapride citrate salt dihydrate; 4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl ]-2-morpholinyl]methyl]benzamide citrate dihydrate; Gasmotin. CAS No. 636582-62-2. Pack Sizes: 1 g. Product ID: B0084-059885. Molecular formula: C21H25ClFN3O3·C6H8O7·2H2O. Mole weight: 650.05. Custom synthesis is available. Send your inquiries for more information. | London |
| N6-benzoyl-5'-o-tert-Butyldimethylsilyl-2'-deoxyadenosine | N6-Benzoyl-5'-O-tert-Butyldimethylsilyl-2'-deoxyadenosine, a synthetic adenosine analog, finds its application in curbing viral infections. It presents inhibitory activities against multiple viruses like HIV-1 and Hepatitis B, restricting their replication by imposing a halt on viral DNA synthesis. Interestingly, this antiviral agent's remedial prowess towards various diseases caused by viruses has consistently stirred researchers' intrigue. Group: Pharmaceutical. Alternative Names: 5'-TBDMS-Bz-dA; N6-benzoyl-5'-O-(tert-butyldimethylsilyl)-2'-deoxyadenosine; N-Benzoyl-5'-O-(tert-butyldimethylsilyl)-2'-deoxyadenosine; N-(9-((2R,4S,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide; Adenosine, N-benzoyl-2'-deoxy-5'-O-[(1,1-dimethylethyl)dimethylsilyl]-. CAS No. 51549-39-4. Pack Sizes: 10 g. Product ID: B1370-024746. Molecular formula: C23H31N5O4Si. Mole weight: 469.61. Custom synthesis is available. Send your inquiries for more information. | London |
| N6-Benzoyl-7'-hydroxy-N-trityl morpholino adenine | N6-Benzoyl-7'-hydroxy-N-trityl morpholino adenine is a vital compound used for various applications, functioning as an inhibitor in biomedical studies related to diseases like cancer and inflammation. Group: Pharmaceutical. Alternative Names: PMO-A Precusor; Morpholino-A(Bz); PMO Adesnosine Precusor; 6-Bz-7'-OH-N-trityl morpholino adenosine; N-[9-[(2R,6S)-6-(Hydroxymethyl)-4-(triphenylmethyl)-2-morpholinyl]-9H-purin-6-yl]benzamide. CAS No. 956139-16-5. Pack Sizes: 1 g. Product ID: B1370-339311. Molecular formula: C36H32N6O3. Mole weight: 596.68. Custom synthesis is available. Send your inquiries for more information. | London |
| Navitoclax-piperazine | Navitoclax-piperazine is a B-cell lymphoma extra large (BCL-XL) inhibitor. Group: Pharmaceutical. Alternative Names: ABT-263-piperazine; (R)-4-(4-((4'-chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((1-(phenylthio)-4-(piperazin-1-yl)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide; 4-(4-{[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl}-1-piperazinyl)-N-[(4-{[(2R)-1-(phenylsulfanyl)-4-(1-piperazinyl)-2-butanyl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl)sulfonyl]benzamide. CAS No. 2143096-93-7. Pack Sizes: 100 mg. Product ID: B1370-380191. Molecular formula: C47H56ClF3N6O5S3. Mole weight: 973.63. Custom synthesis is available. Send your inquiries for more information. | London |
| NCGC00244536 | NCGC00244536 is a potent KDM4A inhibitor (IC50 = 10 nM) that inhibits the in vivo growth of tumors derived from PC3 cells and ex vivo human PCa explants. Group: Pharmaceutical. Alternative Names: KDM4B-IN-B3; KDM4B IN B3; KDM4BINB3; 3-(8-hydroxyquinolin-6-yl)-N-(3-phenylpropyl)benzamide; CHEMBL3785491; BDBM50158844. CAS No. 2003260-55-5. Pack Sizes: 300 mg. Product ID: B0084-007367. Molecular formula: C25H22N2O2. Mole weight: 382.45. Custom synthesis is available. Send your inquiries for more information. | London |
| N-Desmethyl Imatinib | A metabolite of Imatinib, a tyrosine kinase receptor inhibitor used for cancer therapy. Group: Pharmaceutical. Alternative Names: N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)-benzamide; N-Desmethyl Gleevec. CAS No. 404844-02-6. Pack Sizes: 10 mg. Product ID: B2694-473156. Molecular formula: C28H29N7O. Mole weight: 479.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Nifuroxazide | Nifuroxazide is a cell-permeable and orally available nitrofuran-based antidiarrheal agent that effectively suppresses the activation of cellular STAT1/3/5 transcription activity with IC50 of 3 μM against IL-6-induced STAT3 activation in U3A cells. It induces apoptosis in breast cancer cells. Uses: Broad-spectrum nitrofuran antibiotic. Group: Pharmaceutical. Alternative Names: Nifuroxazid; Dicoferin; Diarlidan; Nifuroxazida; 4-hydroxy-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]benzamide. CAS No. 965-52-6. Pack Sizes: 5 g. Product ID: NP3353. Molecular formula: C12H9N3O5. Mole weight: 275.22. Custom synthesis is available. Send your inquiries for more information. | London |
| Nilotinib EP Impurity H | An impurity of Nilotinib, which is a Bcr-Abl inhibitor with IC50 less than 40 nM. Group: Pharmaceutical. Alternative Names: Nilotinib Regio Isomer; 4-Methyl-N-(3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide. CAS No. 641571-15-5. Pack Sizes: 10 mg. Product ID: B1370-242094. Molecular formula: C28H22F3N7O. Mole weight: 529.53. Custom synthesis is available. Send your inquiries for more information. | London |
| Nitazoxanide | Nitazoxanide is a broad-spectrum antiparasitic and broad-spectrum antiviral drug that is used in medicine for the treatment of various helminthic, protozoal, and viral infections. Nitazoxanide is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent. (IC50 for canine influenza virus ranges from 0.17 to 0.21 μM). Uses: Antiparasitic agents. Group: Pharmaceutical. Alternative Names: 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide; N-(5-Nitro-2-thiazolyl)salicylamide Acetate Ester; Nizonide. CAS No. 55981-09-4. Pack Sizes: 500 g. Product ID: BBF-03903. Molecular formula: C12H9N3O5S. Mole weight: 307.28. Custom synthesis is available. Send your inquiries for more information. | London |
| Nitazoxanide-[d4] | The isotope labelled Nitazoxanide which could used as an anthelmintic agent. Uses: The isotope labelled nitazoxanide. Group: Pharmaceutical. Alternative Names: 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide-d4; Alinia-d4; BRN 1225475-d4; Cryptaz-d4; DRG 0242-d4; N-(5-Nitro-2-thiazolyl)salicylamide-d4 Acetate Ester; Nitacure-d4; Nitarid-d4; Nitazoxanida-d4; Nixide-d4; Nixoran-d4; Nizonide-d4. CAS No. 1246819-17-9. Pack Sizes: 5 mg. Product ID: BLP-013105. Molecular formula: C12H5D4N3O5S. Mole weight: 311.31. Custom synthesis is available. Send your inquiries for more information. | London |
| Parimifasor | Parimifasor is an immunomodulator that exhibits anti-inflammatory activity. It is a potential therapy for inflammatory bowel disease (IBD). Group: Pharmaceutical. Alternative Names: 3-chloro-N-[(3-chloro-5-fluoroanilino)-[[5-(trifluoromethyl)-1H-pyrazol-3-yl]amino]methylidene]benzamide. CAS No. 1796641-10-5. Pack Sizes: 5 mg. Product ID: B0084-284779. Molecular formula: C18H11Cl2F4N5O. Mole weight: 460.214. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
